Updated Jul 16, 2026
Novack Jeffrey Adam has filed 4 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $577K.
Jeffrey Adam Novack serves as the Secretary and General Counsel for CareDx, Inc., a company specializing in precision medicine for transplant patients. He has been involved in various SEC filings related to the company, indicating his active role in corporate governance and compliance.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | CDNA | CareDx, Inc. | F — Tax withholding / forfeiture | 997 | $29.25 | $29K |
| 2026-06-09 | CDNA | CareDx, Inc. | F — Tax withholding / forfeiture | 1.3K | $21.95 | $28K |
| 2026-05-06 | CDNA | CareDx, Inc. | S — Open-market sale | 2.7K | $20.68 | $56K |
| 2026-05-04 | CDNA | CareDx, Inc. | F — Tax withholding / forfeiture | 2.9K | $21.50 | $62K |
| 2026-04-07 | CDNA | CareDx, Inc. | F — Tax withholding / forfeiture | 1.9K | $17.82 | $34K |
| 2026-04-03 | CDNA | CareDx, Inc. | F — Tax withholding / forfeiture | 4.0K | $17.87 | $71K |
| 2026-02-04 | CDNA | CareDx, Inc. | S — Open-market sale [10b5-1] | 4.4K | $20.56 | $91K |
| 2026-02-04 | CDNA | CareDx, Inc. | F — Tax withholding / forfeiture [10b5-1] | 3.0K | $20.42 | $61K |
| 2026-02-04 | CDNA | CareDx, Inc. | F — Tax withholding / forfeiture [10b5-1] | 2.5K | $20.42 | $51K |
| 2026-02-04 | CDNA | CareDx, Inc. | A — Grant or award [10b5-1] | 4.3K | $0.00 | |
| 2026-02-04 | CDNA | CareDx, Inc. | A — Grant or award [10b5-1] | 33.0K | $0.00 | |
| 2025-12-05 | CDNA | CareDx, Inc. | S — Open-market sale [10b5-1] | 286 | $19.75 | $6K |
| 2025-12-05 | CDNA | CareDx, Inc. | S — Open-market sale [10b5-1] | 7.0K | $19.15 | $134K |
| 2025-08-05 | CDNA | CareDx, Inc. | S — Open-market sale | 2.7K | $12.79 | $34K |
| 2025-08-01 | CDNA | CareDx, Inc. | F — Tax withholding / forfeiture | 2.9K | $12.22 | $35K |
| 2025-07-07 | CDNA | CareDx, Inc. | F — Tax withholding / forfeiture | 276 | $18.45 | $5K |
| 2025-06-06 | CDNA | CareDx, Inc. | F — Tax withholding / forfeiture | 2.6K | $19.52 | $50K |
| 2025-05-05 | CDNA | CareDx, Inc. | S — Open-market sale | 2.7K | $14.70 | $40K |
| 2025-05-01 | CDNA | CareDx, Inc. | F — Tax withholding / forfeiture | 2.9K | $15.07 | $43K |
| 2025-04-07 | CDNA | CareDx, Inc. | S — Open-market sale | 924 | $17.72 | $16K |
Jeffrey Adam Novack serves as the Secretary and General Counsel for CareDx, Inc., a company specializing in precision medicine for transplant patients. He has been involved in various SEC filings related to the company, indicating his active role in corporate governance and compliance.…
4 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 13 open-market sales ($577K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Novack Jeffrey Adam profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.